Arteannuin B, a biogenetic precursor of artemisinin found in the herb artemisia annua, is active against different bacteria and certain fungal species with potential antimalarial and antitumor activities.

Arteannuin B, a biogenetic precursor of artemisinin found in the herb artemisia annua, is active against different bacteria and certain fungal species with potential antimalarial and antitumor activities.

Arteannuin B, a biogenetic precursor of artemisinin found in the herb artemisia annua, is active against different bacteria and certain fungal species with potential antimalarial and antitumor activities.

Arteannuin B, a biogenetic precursor of artemisinin found in the herb artemisia annua, is active against different bacteria and certain fungal species with potential antimalarial and antitumor activities.

Arteanoflavone is a natural product isolated and purified from the aerial parts of Artemisia hispanica.

Arteanoflavone is a natural product isolated and purified from the aerial parts of Artemisia hispanica.

Artemetin, a natural product isolated and purified from the herbs of Achillea millefolium L., protects endothelial function by acting as antioxidant and antiapoptotic agent and through the activation of ERK1/2 and Akt.

Artemetin acetate is a natural product isolated and purified from the herbs of Achillea millefolium L..

Artemetin acetate is a natural product isolated and purified from the herbs of Achillea millefolium L..

Artemisic acid is a sesquiterpene that can decrease glycerol-3-phosphate dehydrogenase (GPDH) activity in hAMSCs. It is major precursor of artemisinin.

Artemisic acid is a sesquiterpene that can decrease glycerol-3-phosphate dehydrogenase (GPDH) activity in hAMSCs. It is major precursor of artemisinin.

Artemisic acid is a sesquiterpene that can decrease glycerol-3-phosphate dehydrogenase (GPDH) activity in hAMSCs. It is major precursor of artemisinin.

Absinthiin is a weak HIV-1 protease inhibitor isolated and purified from the herbs of Artemisia absinthium.

Absinthiin is a weak HIV-1 protease inhibitor isolated and purified from the herbs of Artemisia absinthium.

Absinthiin is a weak HIV-1 protease inhibitor isolated and purified from the herbs of Artemisia absinthium.

ARV-825 is a PROTAC targeting on BRD4, consisting of a BRD4-ligand JQ-1 linked to a cereblon E3 ligase ligand Pomalidomide, with Kds values of 90nM and 28nM for affinity to BD1 and BD2.

ARV-825 is a PROTAC targeting on BRD4, consisting of a BRD4-ligand JQ-1 linked to a cereblon E3 ligase ligand Pomalidomide, with Kds values of 90nM and 28nM for affinity to BD1 and BD2.

ARV-825 is a PROTAC targeting on BRD4, consisting of a BRD4-ligand JQ-1 linked to a cereblon E3 ligase ligand Pomalidomide, with Kds values of 90nM and 28nM for affinity to BD1 and BD2.

ARV-825 is a PROTAC targeting on BRD4, consisting of a BRD4-ligand JQ-1 linked to a cereblon E3 ligase ligand Pomalidomide, with Kds values of 90nM and 28nM for affinity to BD1 and BD2.

ARV-825 is a PROTAC targeting on BRD4, consisting of a BRD4-ligand JQ-1 linked to a cereblon E3 ligase ligand Pomalidomide, with Kds values of 90nM and 28nM for affinity to BD1 and BD2.

Arvanil is an antagonist of cannabinoid CB1 and vanilloid TRPV1 (VR1) with Ki values are 0.5 and 0.3 μM respectively.

AS-601245 is an inhibitor of the c-Jun NH2-terminal kinase (JNK) (hJNK1: IC50=150nM, hJNK2: IC50=220nM and hJNK3: IC50=70 nM), has neuroprotective properties.

AS-601245 is an inhibitor of the c-Jun NH2-terminal kinase (JNK) (hJNK1: IC50=150nM, hJNK2: IC50=220nM and hJNK3: IC50=70 nM), has neuroprotective properties.

AS-601245 is an inhibitor of the c-Jun NH2-terminal kinase (JNK) (hJNK1: IC50=150nM, hJNK2: IC50=220nM and hJNK3: IC50=70 nM), has neuroprotective properties.

AS-601245 is an inhibitor of the c-Jun NH2-terminal kinase (JNK) (hJNK1: IC50=150nM, hJNK2: IC50=220nM and hJNK3: IC50=70 nM), has neuroprotective properties.

AS-601245 is an inhibitor of the c-Jun NH2-terminal kinase (JNK) (hJNK1: IC50=150nM, hJNK2: IC50=220nM and hJNK3: IC50=70 nM), has neuroprotective properties.

AS-602801 is an ATP-competitive JNK inhibitor with IC50 of 80 nM, 90 nM, and 230 nM for JNK1, JNK2, and JNK3, respectively.

AS-602801 is an ATP-competitive JNK inhibitor with IC50 of 80 nM, 90 nM, and 230 nM for JNK1, JNK2, and JNK3, respectively.

AS-602801 is an ATP-competitive JNK inhibitor with IC50 of 80 nM, 90 nM, and 230 nM for JNK1, JNK2, and JNK3, respectively.

AS-602801 is an ATP-competitive JNK inhibitor with IC50 of 80 nM, 90 nM, and 230 nM for JNK1, JNK2, and JNK3, respectively.

AS-602801 is an ATP-competitive JNK inhibitor with IC50 of 80 nM, 90 nM, and 230 nM for JNK1, JNK2, and JNK3, respectively.